The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Novel RNA-nanoparticle vaccine for the treatment of early melanoma recurrence following adjuvant anti-PD-1 antibody therapy.
 
Bently Patrick Doonan
Honoraria - Curis
Consulting or Advisory Role - Curis; Immunocore; Pfizer
Research Funding - Curis; Regeneron (Inst)
 
Christiana M. Shaw
No Relationships to Disclose
 
Ji-Hyun Lee
No Relationships to Disclose
 
Eugenio Simon Manso
Employment - PharmaLex
Consulting or Advisory Role - PharmaLex
 
Hector Mendez-Gomez
Patents, Royalties, Other Intellectual Property - University of Florida
 
Christina Von Roemeling
Research Funding - Curis
 
Duane Anthony Mitchell
Stock and Other Ownership Interests - iOncologi
Consulting or Advisory Role - Immunomic Therapeutics; Oncorus; Tocagen
Research Funding - Immunomic Therapeutics
Patents, Royalties, Other Intellectual Property - Annias Immunotherapeutics; Celldex; Immunomic Therapeutics; iOncologi
Travel, Accommodations, Expenses - Immunomic Therapeutics
Other Relationship - iOncology
 
Elias Sayour
Consulting or Advisory Role - Siren Biotechnology
Patents, Royalties, Other Intellectual Property - iOncologi
 
Thomas J. George
Consulting or Advisory Role - Avammune Therapeutics; BillionToOne; KAHR Medical; Nihon Medi-Physics; Seagen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BillionToOne (Inst); BioMed Valley Discoveries (Inst); Bristol-Myers Squibb (Inst); Elicio Therapeutics (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Ipsen (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Merck (Inst); OncoC4 (Inst); Seagen (Inst)